Generic placeholder image

Recent Patents on Anti-Infective Drug Discovery

Editor-in-Chief

ISSN (Print): 1574-891X
ISSN (Online): 2212-4071

Epidemiology, Pathogenicity and Emerging Resistances in Staphylococcus pasteuri: From Mammals and Lampreys, to Man

Author(s): Vincenzo Savini, Chiara Catavitello, Azaira Bianco, Andrea Balbinot and Domenico D'Antonio

Volume 4, Issue 2, 2009

Page: [123 - 129] Pages: 7

DOI: 10.2174/157489109788490352

Price: $65

Abstract

Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed.

Keywords: Staphylococcus pasteuri, methicillin, oxacillin, macrolide, lincosamide, streptogramin, tetracyclines, chloramphenicol, fosfomycin


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy